Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani
  • Alfredo Marzano
    Digestive and Liver Disease Dpt., Second Medical Faculty, University of Rome “La Sapienza” at S. Andrea Hospital. Via di Grottarossa 1035-1039, 00189 Rome, Italy, Italy
  • Andrea Marengo
    Affiliation not present
  • Michela di Fonzo
    Affiliation not present
  • Antonella Ferrari
    Affiliation not present
  • Bruno Monarca
    Affiliation not present
  • Gianfranco delle Fave
    Affiliation not present

Abstract

Patients with inactive or occult hepatitis B virus infection and onco-hematological malignancies are at risk for hepatitis flare, hepatic failure and death due to chemotherapy-mediated reactivation. Nucleot(s)ide analogues can reduce reactivation risks and/or hepatitis. However, immuno-mediated phenomena concur to determine liver damage and clinical outcome. We describe two patients with onco-hematological and hepatitis B reactivation after chemotherapy in whom glucocorticoids were added to nucleot(s)ide. Antiviral therapy was effective on replication, while glucocorticoids managed hyperergic response. One patient without underlying liver disease survived, while the second died. In this later autopsy detected cirrhosis, not evident at presentation. This clinical experience suggests that in patients with onco-hematological and persistent liver function tests alterations in spite of effective antiviral response, glucocorticoids could control the effects of immune response. However prognosis and survival are related to the underlying liver status

Keywords

HBV; hematology; hepatitis flare; chemotherapy

Full Text:

PDF
HTML
Submitted: 2014-06-11 12:21:21
Published: 2010-12-13 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
112

Views:
PDF
111
HTML
1111

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185